These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 17312967)
1. Exploration of omega-side chain addition strategies for the syntheses of isocarbacyclin and 15R-16-(m-tolyl)-17,18,19,20-tetranorisocarbacyclin. Sheddan NA; Mulzer J Org Biomol Chem; 2006 Nov; 4(22):4127-30. PubMed ID: 17312967 [TBL] [Abstract][Full Text] [Related]
2. Access to isocarbacyclin derivatives via substrate-controlled enolate formation: total synthesis of 15-deoxy-16-(m-tolyl)- 17,18,19,20-tetranorisocarbacyclin. Sheddan NA; Mulzer J Org Lett; 2005 Nov; 7(23):5115-8. PubMed ID: 16268516 [TBL] [Abstract][Full Text] [Related]
3. Asymmetric synthesis of 3-oxa-15-Deoxy-16-(m-tolyl)-17,18,19,20-tetranorisocarbacyclin and its neuroprotective analogue 15-Deoxy-16-(m-tolyl)-17,18,19,20-tetranorisocarbacyclin based on the conjugate addition-azoalkene-asymmetric olefination strategy. van de Sande M; Gais HJ Chemistry; 2007; 13(6):1784-95. PubMed ID: 17106906 [TBL] [Abstract][Full Text] [Related]
4. Cross metathesis as a general strategy for the synthesis of prostacyclin and prostaglandin analogues. Sheddan NA; Mulzer J Org Lett; 2006 Jul; 8(14):3101-4. PubMed ID: 16805562 [TBL] [Abstract][Full Text] [Related]
5. Synthetic approaches to isocarbacyclin and analogues as potential neuroprotective agents against ischemic stroke. Abu Deiab GI; Croatt MP Bioorg Med Chem; 2019 Jan; 27(2):338-342. PubMed ID: 30545734 [TBL] [Abstract][Full Text] [Related]
6. A novel subtype of prostacyclin receptor in the central nervous system. Watanabe Y; Matsumura K; Takechi H; Kato K; Morii H; Björkman M; Långström B; Noyori R; Suzuki M; Watanabe Y J Neurochem; 1999 Jun; 72(6):2583-92. PubMed ID: 10349870 [TBL] [Abstract][Full Text] [Related]
7. Protective effect of prostaglandin I(2) analogs on ischemic delayed neuronal damage in gerbils. Cui Y; Kataoka Y; Satoh T; Yamagata A; Shirakawa N; Watanabe Y; Suzuki M; Yanase H; Kataoka K; Watanabe Y Biochem Biophys Res Commun; 1999 Nov; 265(2):301-4. PubMed ID: 10558861 [TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography studies using (15R)-16-m-[11C]tolyl-17,18,19,20-tetranorisocarbacyclin methyl ester for the evaluation of hepatobiliary transport. Takashima T; Nagata H; Nakae T; Cui Y; Wada Y; Kitamura S; Doi H; Suzuki M; Maeda K; Kusuhara H; Sugiyama Y; Watanabe Y J Pharmacol Exp Ther; 2010 Nov; 335(2):314-23. PubMed ID: 20716623 [TBL] [Abstract][Full Text] [Related]
9. Diastereoselective total synthesis of isocarbacyclin from L-ascorbic acid. Ishikawa T; Ishii H; Shimizu K; Nakao H; Urano J; Kudo T; Saito S J Org Chem; 2004 Nov; 69(23):8133-5. PubMed ID: 15527306 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotection by a central nervous system-type prostacyclin receptor ligand demonstrated in monkeys subjected to middle cerebral artery occlusion and reperfusion: a positron emission tomography study. Cui Y; Takamatsu H; Kakiuchi T; Ohba H; Kataoka Y; Yokoyama C; Onoe H; Watanabe Y; Hosoya T; Suzuki M; Noyori R; Tsukada H; Watanabe Y Stroke; 2006 Nov; 37(11):2830-6. PubMed ID: 17008612 [TBL] [Abstract][Full Text] [Related]
11. Fully stereocontrolled syntheses of 3-oxacarbacyclin and carbacyclin by the conjugate addition-azoalkene-asymmetric olefination strategy. Kim M; Gais HJ J Org Chem; 2006 Jun; 71(12):4642-50. PubMed ID: 16749799 [TBL] [Abstract][Full Text] [Related]
12. Asymmetric synthesis of the highly potent anti-metastatic prostacyclin analogue cicaprost and its isomer isocicaprost. Lerm M; Gais HJ; Cheng K; Vermeeren C J Am Chem Soc; 2003 Aug; 125(32):9653-67. PubMed ID: 12904032 [TBL] [Abstract][Full Text] [Related]
13. Novel synthetic strategies for the preparation of prostacyclin and prostaglandin analogues--off the beaten track. Sheddan NA; Czybowski M; Mulzer J Chem Commun (Camb); 2007 Jun; (21):2107-20. PubMed ID: 17520108 [TBL] [Abstract][Full Text] [Related]
14. Development of a common fully stereocontrolled access to the medicinally important and promising prostacyclin analogues iloprost, 3-oxa-iloprost and cicaprost. Gais HJ; Kramp GJ; Wolters D; Reddy LR Chemistry; 2006 Jul; 12(21):5610-7. PubMed ID: 16708414 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of 11C/13C-labelled prostacyclins. Björkman M; Andersson Y; Doi H; Kato K; Suzuki M; Noyori R; Watanabe Y; Långström B Acta Chem Scand (Cph); 1998 May; 52(5):635-40. PubMed ID: 9586195 [TBL] [Abstract][Full Text] [Related]
16. CNS-specific prostacyclin ligands as neuronal survival-promoting factors in the brain. Satoh T; Ishikawa Y; Kataoka Y; Cui Y; Yanase H; Kato K; Watanabe Y; Nakadate K; Matsumura K; Hatanaka H; Kataoka K; Noyori R; Suzuki M; Watanabe Y Eur J Neurosci; 1999 Sep; 11(9):3115-24. PubMed ID: 10510175 [TBL] [Abstract][Full Text] [Related]
17. Syntheses and biological activities of chemically stable prostacyclin mimics with cis-bicyclo[4.3.0]nonene ring system: the novel homoisocarbacyclin analogues. Narita S; Takahashi A; Aoki T; Sato H; Satoh S; Yamada S; Kudo M; Yamaguchi T; Kogi K; Shibasaki M Bioorg Med Chem; 1993 Aug; 1(2):77-118. PubMed ID: 8081847 [TBL] [Abstract][Full Text] [Related]
18. PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me. Takashima T; Kitamura S; Wada Y; Tanaka M; Shigihara Y; Ishii H; Ijuin R; Shiomi S; Nakae T; Watanabe Y; Cui Y; Doi H; Suzuki M; Maeda K; Kusuhara H; Sugiyama Y; Watanabe Y J Nucl Med; 2012 May; 53(5):741-8. PubMed ID: 22499612 [TBL] [Abstract][Full Text] [Related]
19. Specific ligand for a central type prostacyclin receptor attenuates neuronal damage in a rat model of focal cerebral ischemia. Takamatsu H; Tsukada H; Watanabe Y; Cui Y; Kataoka Y; Hosoya T; Suzuki M; Watanabe Y Brain Res; 2002 Jan; 925(2):176-82. PubMed ID: 11792366 [TBL] [Abstract][Full Text] [Related]